Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

Objectives: The combination of chemotherapy and immune checkpoint inhibitors (chemo-ICI) has become the new standard of treatment for extensive-stage small cell lung cancer (ES-SCLC). Recently, slight changes in interstitial shadows, defined as interstitial lung abnormalities (ILA), have been identi...

Full description

Bibliographic Details
Main Authors: Kiyoko Fukuda, Naoko Katsurada, Yoshitaka Kawa, Miyako Satouchi, Kazumi Kaneshiro, Masataka Matsumoto, Rei Takamiya, Yukihisa Hatakeyama, Ryota Dokuni, Kanoko Matsumura, Masahiro Katsurada, Kyosuke Nakata, Sho Yoshimura, Motoko Tachihara
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Heliyon
Subjects:
Small cell lung cancer
Interstitial lung abnormalities
Drug-induced interstitial lung disease
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023076715

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023076715

Similar Items